Comparing the effectiveness of Atazanavir/Ritonavir/ Dolutegravir/Hydroxychloroquine and Lopinavir/Ritonavir/ Hydroxychloroquine treatment regimens in COVID‐19 patients ISI IF: 2.327 Q1 2021
